|

What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery

RECRUITINGN/ASponsored by University of Alberta
Actively Recruiting
PhaseN/A
SponsorUniversity of Alberta
Started2023-06-26
Est. completion2026-06-01
Eligibility
Age18 Years – 99 Years
SexFEMALE
Healthy vol.Accepted

Summary

This study will look at whether females who have previously had breast surgery and radiation and are undergoing repeat breast surgery require any post operative interventions. The reason the investigators are conducting this study is because females who have undergone breast radiation are at higher risk of wound complications following breast surgery. The investigators will randomize recruited female participants into three arms, one which is post operative antibiotics for one week, one which is a wound VAC, and one which is no intervention. The investigators goal is to identify whether these patients will require any postoperative interventions.

Eligibility

Age: 18 Years – 99 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female
* \> 18 years of age
* Previous breast surgery and ipsilateral breast irradiation
* Requiring repeat breast surgery

Exclusion Criteria:

* Male
* \<18 years of age,
* Currently on antibiotic therapy for other indications
* Known hypersensitivity to trimethoprim or sulfonamides,
* History of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides
* Documented megaloblastic anemia due to folate deficiency
* Currently pregnant or breastfeeding, and
* Marked hepatic damage
* Severe renal insufficiency
* Severe sensitivity or allergy to silicone adhesive

Conditions2

Breast CancerCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.